Federal contract award

75N96021F00003

TASK ORDER 3R - PROTOCOL DEVELOPMENT AND SUPPORT

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Health and Human Services
OfficeNATIONAL INSTITUTE OF HEALTH NIEHS
NAICS541712
PSCAJ11 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH
Parent award / vehicleHHSN273201600002I
Set-asideNot reported
Pricing typeCOST PLUS FIXED FEE
Obligations$3.1M
Current contract value$3.1M
Potential contract value / ceiling$3.1M
Start dateJun 1, 2021
Current end dateNov 30, 2026
Potential end dateNov 30, 2026
Latest award activityAug 7, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 14 of 14 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Aug 7, 2026P00013$-89.3KTO ADMINISTRATIVELY DE-OBLIGATE UNEXPENDED AND EXPIRING FISCAL YEAR 2021 FUNDING IN ACCORDANCE WITH 31 U.S.C. SECTION 1552 (A), IN PREPARATION FOR SEPTEMBER 30, 2026, CLOSING OF THE PERIOD OF AVAILABILITY OF THESE FISCAL YEAR FUNDS.
May 26, 2026P00012$109.2KNIEHS: R&D: PROTOCOL DEVELOPMENT AND SUPPORT: TASK ORDER 3R: SEVERABLE
Aug 20, 2025P00011$121.3KPROTOCOL DEVELOPMENT AND SUPPORT: TASK ORDER 3R - 1) INCREMENTALLY FUND OPTION PERIOD 4 CLIN1.
May 14, 2025P00010$40.4KTASK ORDER 3R - 1) EXERCISE OPTION PERIOD 4 CLIN 1; 2) INCREMENTALLY FUND OPTION PERIOD 4 CLIN1; 3) CLIN 3 NO COST EXTENSION
Sep 4, 2024P00009$79.0KTASK ORDER 3R - THIS MODIFICATION IS HEREBY ISSUED TO 1)INCREMENTALLY FUND OPTION PERIOD THREE OF THE CLIN1: PROTOCOL DEVELOPMENT AND SUPPORT - CORE STUDIES IN THE AMOUNT OF $78,957, 2) INCORPORATE UPDATES TO SECTIONS F AND H OF THE TASK ORDER TO ALI
May 28, 2024P00008$280.1KTASK ORDER 3R - EXERCISE OPTION PERIOD 3 FOR CLIN1 & CLIN2 AND INCREMENTALLY FUND EACH CLIN
Sep 14, 2023P00007$0TASK ORDER 3R - ADMINISTRATIVE CORRECTION MODIFICATION.
Aug 31, 2023P00006$200.3KTASK ORDER 3R - CLIN3
May 18, 2023P00005$547.2KTASK ORDER 3R - EXERCISE OPTION PERIOD 2 FOR CLIN1 & CLIN2
Aug 4, 2022P00004$0TASK ORDER 3R - PROTOCOL DEVELOPMENT AND SUPPORT
May 26, 2022P00003$534.6KTASK ORDER 3R - PROTOCOL DEVELOPMENT AND SUPPORT
Sep 16, 2021P00002$203.2KTASK ORDER 3R - PROTOCOL DEVELOPMENT AND SUPPORT
Sep 3, 2021P00001$780.1KTASK ORDER 3R - PROTOCOL DEVELOPMENT AND SUPPORT
May 27, 20210$330.0KTASK ORDER 3R - PROTOCOL DEVELOPMENT AND SUPPORT

Estimated positioning window

Nov 1, 2026 – Jan 30, 2027

Recompete signal:
75/100

Why this recompete signal

Contract timing and recorded acquisition signals at the time of calculation.

Stored score: 75/100. Available recorded signals: 70 points.

Contract end 2026-11-30 (29 days from calculation)
+35 points
20 historical awards in this buyer and category group
+15 points
14 recorded award transactions
+10 points
Latest award action: 2026-08-07
+5 points
Parent award identifier recorded
+5 points
Solicitation identifier recorded
+0 points
Linked official forecast
+0 points
Calculated on
2026-11-01 10:17:53.997580+00:00

The historical group combines buyer, NAICS, and PSC. Multiple awards in this group do not by themselves establish repeated competitions.

Rule-based research score; it does not measure your chance of winning.

This older calculation does not retain a complete reproducible breakdown. Missing or changed inputs are not assigned invented points: Original award-value bonus input.

USAspending award record

. Rule-based research score; positioning dates are estimates.

Recompete score calculated Nov 1, 2026.

Research next steps

  1. Check the linked forecast or SAM for a confirmed solicitation and current timing.
  2. Confirm the ordering vehicle and your eligibility or a qualified teaming route.
  3. Review the award scope and buyer evidence before making a bid/no-bid decision.